Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Van Der AA

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Pharmaceutical Research|March 27, 2007
Cellular uptake of cationic polymer-DNA complexes via caveolae plays a pivotal role in gene transfection in COS-7 cellsM A E M van der Aa, U S Huth, S Y Häfele, et al.
BJU International|December 17, 2009
Pathological stage review is indicated in primary pT1 bladder cancerBas W G van Rhijn, Theo H van der Kwast, David M Kakiashvili, et al.
European Urology|May 27, 2008
Microsatellite analysis of voided-urine samples for surveillance of low-grade non-muscle-invasive urothelial carcinoma: feasibility and clinical utility in a prospective multicenter study (Cost-Effectiveness of Follow-Up of Urinary Bladder Cancer trial [CEFUB])Madelon N M van der Aa, Ellen C Zwarthoff, Ewout W Steyerberg, et al.
Gynecologic Oncology|August 28, 2022
Mainstream germline genetic testing for patients with epithelial ovarian cancer leads to higher testing rates and a reduction in genetics-related healthcare costs from a healthcare payer perspectiveK Bokkers, G W J Frederix, M E Velthuizen, et al.
Reproduction & Fertility|November 7, 2025
Views of male childhood cancer survivors on fertility preservation and restorationJillis van Maaren, Nienke de Graeff, Jaap G den Hartogh, et al.
European Urology|January 2, 2008
Prediction of progression of non-muscle-invasive bladder cancer by WHO 1973 and 2004 grading and by FGFR3 mutation status: a prospective studyMaximilian Burger, Madelon N M van der Aa, Johanna M M van Oers, et al.
European Urology|November 1, 2011
A new and highly prognostic system to discern T1 bladder cancer substageBas W G van Rhijn, Theo H van der Kwast, Sultan S Alkhateeb, et al.
BJU International|March 28, 2012
Prognostic value of molecular markers, sub-stage and European Organisation for the Research and Treatment of Cancer risk scores in primary T1 bladder cancerBas W G van Rhijn, Liyang Liu, André N Vis, et al.
Journal of Cancer Survivorship : Research and Practice|July 1, 2026
Fatigue after pediatric bone sarcoma: prevalence and associated factors in pediatric and adult patients and survivors after treatmentHinke van der Hoek, Heleen Maurice-Stam, Laura R Beek, et al.
BMJ (Clinical Research Ed.)|May 17, 2012
Effectiveness of dementia follow-up care by memory clinics or general practitioners: randomised controlled trialEls J Meeuwsen, René J F Melis, Geert C H M Van Der Aa, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Pharmaceutical Research|March 27, 2007
Cellular uptake of cationic polymer-DNA complexes via caveolae plays a pivotal role in gene transfection in COS-7 cellsM A E M van der Aa, U S Huth, S Y Häfele, et al.
BJU International|December 17, 2009
Pathological stage review is indicated in primary pT1 bladder cancerBas W G van Rhijn, Theo H van der Kwast, David M Kakiashvili, et al.
European Urology|May 27, 2008
Microsatellite analysis of voided-urine samples for surveillance of low-grade non-muscle-invasive urothelial carcinoma: feasibility and clinical utility in a prospective multicenter study (Cost-Effectiveness of Follow-Up of Urinary Bladder Cancer trial [CEFUB])Madelon N M van der Aa, Ellen C Zwarthoff, Ewout W Steyerberg, et al.
Gynecologic Oncology|August 28, 2022
Mainstream germline genetic testing for patients with epithelial ovarian cancer leads to higher testing rates and a reduction in genetics-related healthcare costs from a healthcare payer perspectiveK Bokkers, G W J Frederix, M E Velthuizen, et al.
Reproduction & Fertility|November 7, 2025
Views of male childhood cancer survivors on fertility preservation and restorationJillis van Maaren, Nienke de Graeff, Jaap G den Hartogh, et al.
European Urology|January 2, 2008
Prediction of progression of non-muscle-invasive bladder cancer by WHO 1973 and 2004 grading and by FGFR3 mutation status: a prospective studyMaximilian Burger, Madelon N M van der Aa, Johanna M M van Oers, et al.
European Urology|November 1, 2011
A new and highly prognostic system to discern T1 bladder cancer substageBas W G van Rhijn, Theo H van der Kwast, Sultan S Alkhateeb, et al.
BJU International|March 28, 2012
Prognostic value of molecular markers, sub-stage and European Organisation for the Research and Treatment of Cancer risk scores in primary T1 bladder cancerBas W G van Rhijn, Liyang Liu, André N Vis, et al.
Journal of Cancer Survivorship : Research and Practice|July 1, 2026
Fatigue after pediatric bone sarcoma: prevalence and associated factors in pediatric and adult patients and survivors after treatmentHinke van der Hoek, Heleen Maurice-Stam, Laura R Beek, et al.
BMJ (Clinical Research Ed.)|May 17, 2012
Effectiveness of dementia follow-up care by memory clinics or general practitioners: randomised controlled trialEls J Meeuwsen, René J F Melis, Geert C H M Van Der Aa, et al.
Pageof 6